| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | E.coli-derived human DDX58/RIG-1 recombinant protein (Position: K203-K925) was used as the immunogen for the RIGI antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
RIGI Antibody / DDX58 is an antibody targeting RIGI. Host: Rabbit. Polyclonal. Format: Lyophilized. Applications: WB, IHC, FACS, ELISA.
Key elements and design rationale
- Target: RIGI.
- Immunogen: E.coli-derived human DDX58/RIG-1 recombinant protein (Position: K203-K925) was used as the immunogen for the RIGI antib….
- Species reactivity: Human.
- Conjugate: Unconjugated (no label listed).
Biological background (from provided description)
RIGI antibody detects Retinoic acid-inducible gene I protein, encoded by the DDX58 gene on chromosome 9p21. RIGI antibody is widely applied in studies of innate immunity, antiviral defense, and RNA sensing pathways. RIG-I is a cytoplasmic pattern recognition receptor (PRR) belonging to the RIG-I-like receptor (RLR) family, which also includes MDA5 and LGP2.
Common research applications
- WB: relative abundance and band pattern assessment using appropriate controls.
- IHC: tissue distribution assessment; interpret with matched controls.
Notes for experimental interpretation
- Account for isoforms, paralogs, and post-translational modifications when interpreting signal.
- Support specificity with biological controls (e.g., KO/KD where available) and technical controls (e.g., secondary-only/isotype).
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
